{{Rsnum
|rsid=12980602
|Chromosome=19
|position=39262180
|Orientation=plus
|GMAF=0.2319
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(C;C)
|geno2=(C;T)
|geno3=(T;T)
}}{{ population diversity
| geno1=(C;C)
| geno2=(C;T)
| geno3=(T;T)
| CEU | 8.8 | 27.4 | 63.7
| HCB | 0.7 | 18.2 | 81.0
| JPT | 0.0 | 24.1 | 75.9
| YRI | 7.6 | 41.4 | 51.0
| ASW | 10.5 | 45.6 | 43.9
| CHB | 0.7 | 18.2 | 81.0
| CHD | 1.8 | 18.3 | 79.8
| GIH | 10.9 | 39.6 | 49.5
| LWK | 6.4 | 37.3 | 56.4
| MEX | 15.5 | 44.8 | 39.7
| MKK | 6.0 | 27.5 | 66.4
| TSI | 6.9 | 40.2 | 52.9
| HapMapRevision=28
}}{{PMID Auto
|PMID=23652058
|Title=Gene polymorphisms of interleukin-28, p21-activated protein kinases 4, and response to interferon-α based therapy in Chinese patients with chronic hepatitis B
}}

{{PMID Auto
|PMID=23586360
|Title=Association between gene polymorphisms of IL-28 and response to lamivudine in Chinese rural patients with chronic hepatitis B.
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | Affy GenomeWide 6}}
{{on chip | Illumina Human 1M}}